By Chris Wack
Astrana Health shares fell after the healthcare company reported a surprise fourth-quarter loss.
The stock was down 30%, to $24.31, midday Friday after hitting a three-year low of $23.12 earlier in the session. Shares have lost 44% in the past 12 months.
The Alhambra, Calif., company on Thursday said it had a quarterly loss of $7 million, or 15 cents a share, compared with earnings of $12.4 million, or 26 cents a share, in the same quarter last year. Analysts polled by FactSet were looking for earnings of $5.3 million, or 10 cents a share.
Revenue for the quarter was $665.2 million, compared with last year's $353 million and the $617.2 million analysts were looking for.
For 2025, the company is looking for revenue of $2.5 billion to $2.7 billion, compared with the $2.595 billion analysts are forecasting. The guidance includes $15 million in expected costs associated with continued strategic investments in automation and artificial intelligence, as well as continuing and expected integration costs associated with planned acquisitions. It doesn't include contributions from any acquisitions which haven't yet closed.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
February 28, 2025 13:52 ET (18:52 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。